Protocoles de recherche en cours
GRP78 et BARD1 : Déterminer la valeur de GRP78 et BARD1 comme marqueurs du cancer de l'ovaire.
Investigateurs : Petignat P, Cohen M,
Organisme : Hôpitaux Universitaires de Genève, Projet Recherche et Développement (PRD)
Montant : FRS 100'000.–
Etude de phase III randomisée multicentrique comparant la tolérance et la sécurité de l’association bévacizumab plus paclitaxel à celle de l’association bévacizumab, cyclophosphamide et capécitabine dans le traitement du cancer du sein inopérable ou métastatique.
Organisme : SAKK
Investigateur HUG : Bodmer A.
Etude multicentrique de phase I/II, évaluant la sécurité, la tolérance, la pharmacocinétique et l’efficacité du médicament AZD8931 en association avec le paclitaxel chez des patients et patientes souffrant d’une tumeur solide à un stade avancé et chez des patientes souffrant d’un cancer du sein localement avancé et/ou métastatique avec faible expression du HER2.
Organisme : AstraZeneca
Investigateur HUG : Bodmer A.
Etude AMAROS 10981: "After Mapping Axilla: Radiotherapie Or Surgery". Etude internationale, de phase III, randomisée, "follow-up". En cas de ganglion sentinelle positif: Curage axillaire versus Rx-Thérapie. Follow-up 10 ans.
Organisme: EORTC .
Investigateur principal HUG: P. Petignat
Etude multicentrique de phase III, randomisée, en double aveugle, contrôlée par placebo sur l’évérolimus en association avec le trastuzumab et le paclitaxel dans le traitement de première ligne chez les femmes atteintes d’un cancer du sein localement avancé ou métastatique HER2-positif.
Organisme : Novartis
Investigateur HUG : Bodmer A.
Utilisation d’un anti-transpirant local pour la prévention de l’érythrodysesthésie palmo-plantaire (EPP) chez les patient(e)s traité(e)s avec la doxorubicine liposomale (Caelyx®). Etude multicentrique, de phase III randomisée, en double aveugle
Organisme : SAKK
Investigateur HUG : Bodmer A.
Feasibility and effectiveness of cervical cancer screening at health district level: Pilot project in Baham, West province of Cameroon.
Investigateurs: Petignat P, Tebeu PM
Organisme: Hôpitaux Universitaires de Genève, Projet Recherche et Développement (PRD)
Montant : USD 29'865.-
GRP78 Nouveau Marqueur Diagnostique et Pronostique des Maladies Trophoblastiques.
Investigateurs : Petignat P, Cohen M, Finci V, Epiney M.
Organisme : Hôpitaux Universitaires de Genève, Projet Recherche et Développement (PRD)
Montant : FRS 50'000.-
EORTC 10054 - Etude de Phase I-II de lapatinib et docétaxel en traitement néo-adjuvant chez des patientes ayant un cancer du sein HER-2 positif, localement avancé/inflammatoire ou opérable.
Organisme : EORTC
Investigateur HUG : Nobahar M, Bodmer A
IBIS-II « Prévention » :Etude internationale multicentrique d’anastrazole versus placebo chez les femmes ménopausées à risque accru de cancer du sein.
Organisme : SAKK
Investigateur HUG : Chappuis P, Benusiglio P
IBIS-II « DCIS » : Etude internationale multicentrique randomisée de tamoxifène versus anastrazole chez les femmes ménopausées ayant un cancer canalaire in situ du sein.
Organisme : SAKK
Investigateur HUG : Vlastos G, Chappuis P
PTM : Recherche de modifications post-traductionnelles des protéines sanguines induites par des médicaments
Organisme : HUG
Investigateur HUG : Hochstrasser D
Dépistage prospectif du syndrome de Lynch ou syndrome du cancer colorectal héréditaire non polyposique (HNPCC) dans les populations genevoise et valaisanne
Organisme : OncoSuisse / Ligue contre le cancer
Investigateur HUG : Chappuis P
Publications
Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model.
Feki A, Berardi P, Bellingan G, Major A, Krause KH, Petignat P, Zehra R, Pervaiz S, Irminger-Finger I.
Crit Rev Oncol Hematol. 2009 Jan 27. [Epub ahead of print]
PMID: 19179094 [PubMed - as supplied by publisher]
Positive Adnexal or Uterine Serosal Involvement in Stage IIIC Endometrial Cancer Is an Adverse Factor for Recurrence.
Hétu V, Petignat P, Wu Y, Drouin P, Sauthier P, Provencher D, Gauthier P.
Gynecol Obstet Invest. 2008 Dec 17;67(3):173-177. [Epub ahead of print]
PMID: 19088481 [PubMed - as supplied by publisher]
Magnetic resonance imaging to identify risk of lymph node metastasis in patients with endometrial cancer.
Undurraga M, Petignat P, Pelte MF, Jacob S, Dubuisson JB, Loubeyre P.
Int J Gynaecol Obstet. 2009 Mar;104(3):233-5. Epub 2008 Nov 25.
PMID: 19036368 [PubMed - in process]
Normal pregnancy or neoplasia?
Rozenholc A, Petignat P.
BMJ. 2008 Oct 29;337:a2107. doi: 10.1136/bmj.a2107. No abstract available.
PMID: 18974041 [PubMed - indexed for MEDLINE]
Is the field of breast imaging moving toward broader use of MR imaging?
Loubeyre P, Petignat P.
Radiology. 2008 Nov;249(2):721; author reply 721-2. No abstract available.
PMID: 18936324 [PubMed - indexed for MEDLINE]
Gynecological malignancies in Maroua, Cameroon.
Tebeu PM, Petignat P, Mhawech-Fauceglia P.
Int J Gynaecol Obstet. 2009 Feb;104(2):148-9. Epub 2008 Oct 15. No abstract available.
PMID: 18926532 [PubMed - indexed for MEDLINE]
Should we modify the current FIGO staging system for early-stage cervical cancer?
Petignat P, Loubeyre P.
Expert Rev Anticancer Ther. 2008 Jul;8(7):1015-7. No abstract available.
PMID: 18588447 [PubMed - indexed for MEDLINE]
Laparoscopy in the management of endometrial cancer
Petignat P, Stucki D, Altermatt HJ, Seydoux J, Jacob S, Brioschi PA, Fink D, Fehr M, Delaloye JF, Loubeyre P, Hohl M, Mueller M, Dubuisson JB.
Rev Med Suisse. 2008 Apr 16;4(153):995-8. French.
PMID: 18549088 [PubMed - indexed for MEDLINE]
Outcome of uterine clear cell carcinomas compared to endometrioid carcinomas and poorly-differentiated endometrioid carcinomas.
Petignat P, Usel M, Gauthier P, Popowski Y, Pelte MF, Bouchardy C, Verkooijen HM.
Eur J Gynaecol Oncol. 2008;29(1):57-60.
PMID: 18386465 [PubMed - indexed for MEDLINE]
What's new in gynecology and obstetrics?
Petignat P, de Tejada MB, Irion O, Boulvain M.
Rev Med Suisse. 2008 Jan 9;4(139):24-7. Review. French.
PMID: 18251211 [PubMed - indexed for MEDLINE]
Diagnosis and management of cervical cancer.
Petignat P, Roy M.
BMJ. 2007 Oct 13;335(7623):765-8. Review. No abstract available.
PMID: 17932207 [PubMed - indexed for MEDLINE]
Advancing women's cancer care
Petignat P, Gotlieb W.
Gynakol Geburtshilfliche Rundsch. 2007;47(4):240-2. No abstract available.
PMID: 17914271 [PubMed - indexed for MEDLINE]
The attitude and knowledge of cervical cancer by Cameroonian women; a clinical survey conducted in Maroua, the capital of Far North Province of Cameroon.
Tebeu PM, Major AL, Rapiti E, Petignat P, Bouchardy C, Sando Z, de Bernis L, Ali L, Mhawech-Fauceglia P.
Int J Gynecol Cancer. 2008 Jul-Aug;18(4):761-5. Epub 2007 Sep 14.
PMID: 17868337 [PubMed - indexed for MEDLINE]
Diagnosis and management of vulvar intraepithelial neoplasias and invasive vulvar cancers
Sauthier P, Petignat P.
Gynakol Geburtshilfliche Rundsch. 2007;47(2):88-93. German.
PMID: 17440270 [PubMed - indexed for MEDLINE]
Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis.
Petignat P, Faltin DL, Bruchim I, Tramèr MR, Franco EL, Coutlée F.
Gynecol Oncol. 2007 May;105(2):530-5. Epub 2007 Feb 28. Review.
PMID: 17335880 [PubMed - indexed for MEDLINE]
Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
Petignat P, du Bois A, Bruchim I, Fink D, Provencher DM.
Crit Rev Oncol Hematol. 2007 May;62(2):137-47. Epub 2006 Dec 26. Review.
PMID: 17188887 [PubMed - indexed for MEDLINE]
Advancing women's cancer care. Report from the 37th Annual Meeting of the Society of Gynecologic Oncologists, Palm Springs, Calif., USA, March 22-26, 2006.
Mayer Hope J, Bruchim I, Blank SV, Petignat P.
Gynakol Geburtshilfliche Rundsch. 2006;46(4):214-7. No abstract available.
PMID: 17068405 [PubMed - indexed for MEDLINE]
Long-term survival of patients with apparent early-stage (FIGO I-II) epithelial ovarian cancer: a population-based study.
Petignat P, de Weck D, Goffin F, Vlastos G, Obrist R, Luthi JC.
Gynecol Obstet Invest. 2007;63(3):132-6. Epub 2006 Jan 9.
PMID: 17057398 [PubMed - indexed for MEDLINE]
Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta.
Petignat P, Laurini R, Goffin F, Bruchim I, Bischof P.
Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1679-84.
PMID: 16884384 [PubMed - indexed for MEDLINE]
Cervical cancer screening: current status and perspectives
Petignat P, Bouchardy C, Sauthier P.
Rev Med Suisse. 2006 May 17;2(66):1308-9, 1311-2. Review. French.
PMID: 16775991 [PubMed - indexed for MEDLINE]
Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.
Coutlée F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, Boyle S, Hankins C, Vézina S, Coté P, Macleod J, Voyer H, Forest P, Walmsley S; Canadian Women's HIV study Group, Franco E.
J Clin Microbiol. 2006 Jun;44(6):1998-2006.
PMID: 16757590 [PubMed - indexed for MEDLINE]
Chylous ascites after pelvic lymph node dissection for gynecologic cancer.
Williams C, Petignat P, Alobaid A, Provencher D, Gauthier P.
Eur J Surg Oncol. 2007 Apr;33(3):399-400. Epub 2006 May 8. No abstract available.
PMID: 16682167 [PubMed - indexed for MEDLINE]
New aspects in gynecologic oncology.
Petignat P, Alobaid A, Bruchim I, Goffin F.
Gynakol Geburtshilfliche Rundsch. 2006;46(1-2):72-4. No abstract available.
PMID: 16468165 [PubMed - indexed for MEDLINE]
Adjuvant therapy for patients with stage I papillary serous endometrial cancer.
Alobaid A, Bruchim I, Verkooijen H, Gauthier P, Petignat P.
Eur J Surg Oncol. 2006 Apr;32(3):358-62. Epub 2006 Jan 18. Review.
PMID: 16414233 [PubMed - indexed for MEDLINE]
Cervical cancer in pregnant women: laparoscopic evaluation before delaying treatment.
Stan C, Megevand E, Irion O, Wang C, Bruchim I, Petignat P.
Eur J Gynaecol Oncol. 2005;26(6):649-50.
PMID: 16398229 [PubMed - indexed for MEDLINE]
Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence.
Petignat P, Jolicoeur M, Alobaid A, Drouin P, Gauthier P, Provencher D, Donath D, Van Nguyen T.
Gynecol Oncol. 2006 Jun;101(3):445-9. Epub 2005 Dec 28.
PMID: 16386785 [PubMed - indexed for MEDLINE]
Self-sampling is associated with increased detection of human papillomavirus DNA in the genital tract of HIV-seropositive women.
Petignat P, Hankins C, Walmsley S, Money D, Provencher D, Pourreaux K, Kornegay J, Rouah F, Coutlée F; Canadian Women's HIV Study Group.
Clin Infect Dis. 2005 Aug 15;41(4):527-34. Epub 2005 Jul 14.
PMID: 16028163 [PubMed - indexed for MEDLINE]
Age-related performance of human papillomavirus testing used as an adjunct to cytology for cervical carcinoma screening in a population with a low incidence of cervical carcinoma.
Petignat P, Faltin D, Goffin F, Billieux MH, Stucki D, Sporri S, Vassilakos P.
Cancer. 2005 Jun 25;105(3):126-32.
PMID: 15822123 [PubMed - indexed for MEDLINE]
Treatments patterns of vulvar cancer in the elderly.
Vlastos AT, Usel M, Beffa V, Petignat P, Neyroud-Caspar I, Bouchardy C, Vlastos G.
Surg Oncol. 2004 Dec;13(4):187-91.
PMID: 15615655 [PubMed - indexed for MEDLINE]
Poorer survival of elderly patients with ovarian cancer: a population-based study.
Petignat P, Fioretta G, Verkooijen HM, Vlastos AT, Rapiti E, Bouchardy C, Vlastos G.
Surg Oncol. 2004 Dec;13(4):181-6.
PMID: 15615654 [PubMed - indexed for MEDLINE]
Pre-eclampsia and peripartum cardiomyopathy in molar pregnancy: clinical implication for maternally imprinted genes.
Billieux MH, Petignat P, Fior A, Mhawech P, Blouin JL, Dahoun S, Vassilakos P.
Ultrasound Obstet Gynecol. 2004 Apr;23(4):398-401.
PMID: 15065193 [PubMed - indexed for MEDLINE]
Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation.
Petignat P, Boulvain M, Vassilakos P.
Obstet Gynecol. 2003 Sep;102(3):642-3; author reply 643.
PMID: 12962958 [PubMed - indexed for MEDLINE]
Importance of the general practitioner in the early detection of ovarian cancer.
Petignat P, Joris F, Faltin D.
Gynecol Oncol. 2003 Aug;90(2):491-2. No abstract available.
PMID: 12893228 [PubMed - indexed for MEDLINE]
Is genetic analysis useful in the routine management of hydatidiform mole?
Petignat P, Billieux MH, Blouin JL, Dahoun S, Vassilakos P.
Hum Reprod. 2003 Feb;18(2):243-9. Review.
PMID: 12571156 [PubMed - indexed for MEDLINE]
Why do ovarian cancer patients not consult a gynecologic oncologist?
Petignat P, Vlastos G.
Gynecol Oncol. 2002 Oct;87(1):157; author reply 158. No abstract available.
PMID: 12468361 [PubMed - indexed for MEDLINE]
Are fertility drugs a risk factor for persistent trophoblastic tumour?
Petignat P, Vassilakos P, Campana A.
Hum Reprod. 2002 Jun;17(6):1610-5.
PMID: 12042286 [PubMed - indexed for MEDLINE]
Use of automated primary screening on liquid-based, thin-layer preparations.
Vassilakos P, Carrel S, Petignat P, Boulvain M, Campana A.
Acta Cytol. 2002 Mar-Apr;46(2):291-5.
PMID: 11917575 [PubMed - indexed for MEDLINE]
Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing.
Vassilakos P, Petignat P, Boulvain M, Campana A.
Br J Cancer. 2002 Feb 1;86(3):382-8.
PMID: 11875704 [PubMed - indexed for MEDLINE]
Brochures à l'usage des professionnels
Brochures disponibles sur le site du GRSSGO
- Fertilité et cancer du sein, éditée en 2008
- Fertilité, cancer de l'ovaire et tumeur borderline de l'ovaire, éditée en 2008
- Fertilité, cancer du col utérin et de l'endomètre, éditée en 2009